Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients

FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product.
FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
MANNITOL OPHTHALMIC; SOLUTION
MANNITOL OPHTHALMIC; SOLUTION, DROPS
MANNITOL OPHTHALMIC; SOLUTION, GEL FORMING, EXTENDED RELEASE
MANNITOL OPHTHALMIC; SUSPENSION
MANNITOL OPHTHALMIC; SUSPENSION, DROPS
MANNITOL ORAL; CAPSULE
MANNITOL ORAL; CAPSULE, ENTERIC COATED PELLETS
MANNITOL ORAL; CAPSULE, HARD GELATIN
MANNITOL ORAL; CAPSULE, SUSTAINED ACTION
MANNITOL ORAL; GRANULE
MANNITOL ORAL; GRANULE, EFFERVESCENT
MANNITOL ORAL; GRANULE, FOR SUSPENSION
MANNITOL ORAL; POWDER
MANNITOL ORAL; POWDER, FOR RECONSTITUTION
MANNITOL ORAL; POWDER, FOR SOLUTION
MANNITOL ORAL; POWDER, FOR SUSPENSION
MANNITOL ORAL; SUSPENSION, SUSTAINED ACTION
MANNITOL ORAL; TABLET
MANNITOL ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED
MANNITOL ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
MANNITOL ORAL; TABLET, COATED
MANNITOL ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
MANNITOL ORAL; TABLET, DISPERSIBLE
MANNITOL ORAL; TABLET, FILM COATED
MANNITOL ORAL; TABLET, ORALLY DISINTEGRATING
MANNITOL ORAL; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
MANNITOL ORAL; TABLET, SUSTAINED ACTION
MANNITOL ORAL; TABLET, SUSTAINED ACTION, FILM COATED
MANNITOL ORAL; TROCHE
MANNITOL RESPIRATORY (INHALATION); POWDER, FOR INHALATION
MANNITOL SUBCUTANEOUS; INJECTABLE
MANNITOL SUBCUTANEOUS; INJECTION
MANNITOL SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION
MANNITOL SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
MANNITOL SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES
MANNITOL SUBCUTANEOUS; POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED
MANNITOL SUBCUTANEOUS; SOLUTION, INJECTION
MANNITOL SUBCUTANEOUS; SUSPENSION, INJECTION
MANNITOL SUBLINGUAL; TABLET
MANNITOL TOPICAL; SOLUTION, DROPS
MANNITOL 60 ORAL; TABLET, ORALLY DISINTEGRATING
MANNITOL M300 ORAL; TABLET, ORALLY DISINTEGRATING
MANNOSE, D- ORAL; TABLET
MAPROFIX TOPICAL; EMULSION, CREAM
MEBROFENIN INTRAVENOUS; INJECTION
MEDICAL ADHESIVE MODIFIED S-15 TRANSDERMAL; FILM, CONTROLLED RELEASE
MEDICAL ANTIFOAM EMULSION C ORAL; SUSPENSION
MEDICAL ANTIFOAM EMULSION C ORAL; TABLET
MEDICAL ANTIFORM A-F EMULSION TOPICAL; EMULSION, CREAM
MEDRONATE DISODIUM INTRAVENOUS; INJECTION
MEDRONATE DISODIUM INTRAVENOUS; POWDER, FOR INJECTION SOLUTION
MEDRONIC ACID INTRAVENOUS; INJECTION
MEDRONIC ACID INTRAVENOUS; POWDER, FOR INJECTION SOLUTION
MEGLUMINE INTRA-ARTERIAL; INJECTION
MEGLUMINE INTRA-ARTICULAR; INJECTION
MEGLUMINE INTRACARDIAC; INJECTION
MEGLUMINE INTRADISCAL; INJECTION
MEGLUMINE INTRAMUSCULAR; INJECTION
MEGLUMINE INTRAUTERINE; INJECTION
MEGLUMINE INTRAUTERINE; SOLUTION
MEGLUMINE INTRAVASCULAR; INJECTION
MEGLUMINE INTRAVENOUS; INFUSION
MEGLUMINE INTRAVENOUS; INJECTION
MEGLUMINE IV(INFUSION); INJECTION
MEGLUMINE ORAL; TABLET
MEGLUMINE PERIARTICULAR; INJECTION
MEGLUMINE URETERAL; SOLUTION
MEGLUMINE URETHRAL; INJECTION
MEGLUMINE URETHRAL; SOLUTION
MELOJEL ORAL; TABLET
MENTHOL BUCCAL; GUM, CHEWING
MENTHOL DENTAL; SOLUTION
MENTHOL INHALATION; AEROSOL, METERED
MENTHOL ORAL; CAPSULE
MENTHOL ORAL; CONCENTRATE
MENTHOL ORAL; POWDER, FOR SOLUTION
MENTHOL ORAL; SOLUTION
MENTHOL ORAL; SOLUTION, ELIXIR
MENTHOL ORAL; SOLUTION, LIQUID, CONCENTRATE, ORAL
MENTHOL ORAL; SUSPENSION
MENTHOL ORAL; SYRUP
MENTHOL ORAL; TABLET
MENTHOL SUBLINGUAL; AEROSOL
MENTHOL TOPICAL; LOTION
MENTHOL TOPICAL; SOLUTION
METAPHOSPHORIC ACID IV(INFUSION); INJECTION
METAPHOSPHORIC ACID ORAL; CAPSULE
METHACRYLIC ACID COPOLYMER ORAL; CAPSULE, DELAYED ACTION
METHACRYLIC ACID COPOLYMER ORAL; CAPSULE, ENTERIC COATED PELLETS
METHACRYLIC ACID COPOLYMER ORAL; CAPSULE, EXTENDED RELEASE
METHACRYLIC ACID COPOLYMER ORAL; CAPSULE, SUSTAINED ACTION
METHACRYLIC ACID COPOLYMER ORAL; GRANULE, ENTERIC COATED
METHACRYLIC ACID COPOLYMER ORAL; TABLET
METHACRYLIC ACID COPOLYMER ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
METHACRYLIC ACID COPOLYMER ORAL; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
METHACRYLIC ACID COPOLYMER ORAL; TABLET, SUSTAINED ACTION
METHACRYLIC ACID COPOLYMER ORAL; TABLET, SUSTAINED ACTION, COATED
METHACRYLIC ACID COPOLYMER TYPE A ORAL; CAPSULE, EXTENDED RELEASE
METHACRYLIC ACID COPOLYMER TYPE A ORAL; TABLET, SUSTAINED ACTION
METHACRYLIC ACID COPOLYMER TYPE A ORAL; TABLET, SUSTAINED ACTION, COATED

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link